Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476
Cancer Vaccines01:30

Cancer Vaccines

338
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
338

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

STOCHASTIC MODELING OF HEMATOPOIETIC STEM CELL DYNAMICS.

bioRxiv : the preprint server for biology·2025
Same author

Loss of ING4 enhances hematopoietic regeneration in multipotent progenitor cells.

PloS one·2025
Same author

In vivo examination of pathogenicity and virulence in environmentally isolated Vibrio vulnificus.

MicrobiologyOpen·2024
See all related articles

Related Experiment Video

Updated: Jun 6, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.3K

Augmentation of Solid Tumor Immunotherapy With IL-12.

Christian Geils1, Katie L Kathrein1

  • 1Department of Biological Sciences, University of South Carolina, Columbia, South Carolina, USA.

The Journal of Gene Medicine
|December 2, 2024
PubMed
Summary

Cytokine immunotherapy, particularly Interleukin-12 (IL-12), shows promise for solid tumors by converting "cold" tumors to "hot." Advanced engineering reduces IL-12 toxicity, enabling effective human treatments.

Keywords:
gene deliverygene therapytumor biologytumor immunologytumor targeting

More Related Videos

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

14.7K
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

643

Related Experiment Videos

Last Updated: Jun 6, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.3K
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

14.7K
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

643

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Immunotherapy is crucial for hematological cancers but less effective for solid tumors due to immune evasion.
  • Solid tumors possess physical and molecular barriers hindering immune destruction.
  • Cytokine immunotherapy aims to overcome these barriers by enhancing anti-tumor immunity.

Purpose of the Study:

  • To review advancements in cytokine immunotherapy for solid tumors.
  • To highlight strategies for overcoming Interleukin-12 (IL-12) associated toxicities.
  • To identify future research directions for effective IL-12 based cancer treatments.

Main Methods:

  • Review of recent studies employing cell and molecular engineering for IL-12 delivery.
  • Analysis of approaches to mitigate systemic immunotoxicity.
  • Evaluation of methods to enhance IL-12 efficacy in solid tumor microenvironments.

Main Results:

  • Engineered approaches have successfully reduced IL-12 toxicity in preclinical and clinical settings.
  • Modified IL-12 delivery systems demonstrate potential for transforming cold tumors into hot, immunologically responsive tumors.
  • Improved therapeutic windows for IL-12 administration are being established.

Conclusions:

  • Cytokine immunotherapy, especially with engineered IL-12, offers a promising strategy to treat solid tumors.
  • Overcoming IL-12 induced immunotoxicity is key to successful clinical translation.
  • Continued development in bioengineering and immunotherapy holds significant potential for solid tumor treatment.